Systemic gene therapy with anti-angiogenic factors inhibits spontaneous breast tumor growth and metastasis in MMTVneu transgenic mice

Gene Therapy

Volumn 8, Issue 1, 2001, Pages 67-70

  Sacco, M G ^a   Catò, E Mira ^a   Ceruti, R ^a,b   Soldati, S ^a,b   Indraccolo, S ^c   Caniatti, M ^b   Scanziani, E ^b   Vezzoni, P ^c  

^a CNR   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c IST Biotechnology Section   (Italy)

Author keywords

Anti angiogenesis; Breast adenocarcinoma; Gene therapy; Liposomes; Metastasis; Transgenic mice

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOSTATIN; DNA; ENDOSTATIN; LIPOSOME; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER INHIBITION; CONTROLLED STUDY; FEMALE; GENE CONSTRUCT; GENE TARGETING; GENE THERAPY; GENETIC CODE; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ADENOCARCINOMA; ANGIOGENESIS INHIBITORS; ANIMALS; FEMALE; GENE THERAPY; HUMANS; LIPOSOMES; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PATHOLOGIC;

ANIMALIA; MURINAE; MUS MUSCULUS;

EID: 0035134335     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301358     Document Type: Article

References (25)

1. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
2. Transgenic mouse models of tumor angiogenesis: The angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models
3. The implications of angiogenesis for the biology and therapy of cancer metastasis
4. Angiostatin: A novel angiogenesis inhibitor that mediates the supression of metastases by a Lewis lung carcinoma
5. Angiostatin induces and sustains dormancy of human primary tumors in mice
6. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
7. Combined effects of angiostatin and ionizing radiation in antitumor therapy
8. Anti-angiogenic therapy of experimental cancer does not induce drug resistance
9. Local regression of breast tumors following intramammary ganciclovir administration in double transgenic mice expressing neu oncogene and herpes simplex virus thymidine kinase
10. Partial regression, yet incomplete eradication of mammary tumors in transgenic mice by retrovirus-mediated HSV-TK transfer in vivo
11. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice
12. Retrovirus-mediated IL-4 gene therapy in spontaneous adenocarcinomas from MMTV-neu transgenic mice
13. Liposome-delivered angiostatin strongly inhibits tumor growth and metastatization in a transgenic model of spontaneous breast cancer
14. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
15. Novel applications of liposomes
16. The matrix-degrading metalloproteinases
17. Matrix metalloproteinases
18. MMP-9/ gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes
19. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover
20. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention
21. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I
22. Matrix metalloproteinases and metastasis
23. TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis
24. Systematic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene
25. Generation of expression plasmids for angiostatin, endostatin and TIMP-2 for cancer gene therapy